Journal of Medicinal Chemistry · 2009 · 44 citations · 33 references
MedicineMolecular BiologyPharmacologyDrug DesignIon Channel BiophysicsMolecular PharmacologyChannel StructureDrug-receptor InteractionsIon Channel PharmacologyLigand BindingMolecular DockingProtein-ligand DockingDocking-based Drug DesignDrug Binding To Ion ChannelsHuman Ether-a-go-go-related Gene (Herg) Channel InhibitionIon Channel Drug BindingIon Channel Structure-function RelationshipsPatch-clamp AnalysisProtein-drug BindingSynergic Bonding
To characterize drug binding to the human ether-a-go-go related gene (hERG) channel, a synergic approach interplaying patch-clamp experiments and a docking study was developed. Mutations were introduced into concatenated dimers of the hERG channel that were assembled into a heterotetramer with mutated diagonal subunits. The binding affinities of three drugs (cisapride, terfenadine, and N-[4-[[1-[2-(6-methyl-2-pyridinyl)ethyl]-4-piperidinyl]carbonyl]phenyl]methanesulfonamide dihydrochloride (E-4031, 1)) to a set of mutant channels were examined electrophysiologically to assess the involved residues, their number, and relative positions. Cisapride and 1 interacted with Tyr652 residues on adjacent subunits, while terfenadine interacted with Tyr652 residues on diagonal, but not on adjacent, subunits. Phe656 was involved in the binding of all three drugs, and Ser624 was found to be only involved in cisapride and 1. The docking models demonstrated that pi-pi and CH-pi interactions rather than cation-pi interaction play a key role in drug binding to the hERG channel.
33
Julie Thompson, Desmond G. Higgins, Toby J. Gibson · Nucleic Acids Research · 1994 · 64.9K citations · Full text
Helen M. Berman · Nucleic Acids Research · 2000 · 39.8K citations
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
Mark Curran, Igor Splawski, Katherine W. Timothy et al. · Cell · 1995 · 2.3K citations · Full text